NEXT PHARMA SOURCING S.A.S Heparin Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Heparin from India and how much does NEXT PHARMA SOURCING S.A.S import?

India exports Heparin to 854 buyers globally worth $68.4M. NEXT PHARMA SOURCING S.A.S imports $2.4M (0.5% market share) with 48 shipments from COLOMBIA.

Q: What is the average order value for NEXT PHARMA SOURCING S.A.S's Heparin imports?

NEXT PHARMA SOURCING S.A.S's average Heparin order value is $49.1K per consignment, based on 48 shipments totaling $2.4M.

Q: Who supplies Heparin to NEXT PHARMA SOURCING S.A.S?

NEXT PHARMA SOURCING S.A.S sources Heparin from 1 verified supplier: GLAND PHARMA LIMITED ($2.4M, 100.0%). Based on 48 customs records.

Q: How does NEXT PHARMA SOURCING S.A.S compare to other Heparin importers?

NEXT PHARMA SOURCING S.A.S ranks #17 among 854 Heparin importers from India with 0.5% market share and 48 shipments.

Q: Who are the top Heparin importers from India?

Top Heparin importers: FRESENIUS KABI USA, LLC ($19.4M), EVERSANA ($13.4M), BOSTON ONCOLOGY ARABIA ($11.2M), FRESENIUS KABI USA LLC ($3.5M), PHARMACEUTICAL TECHNOLOGY ($3.0M).

Suresh Sormare

Heparin

India Pharmaceutical Trade Intelligence

$352.8M391 Suppliers137 CountriesHS 30049099

ExportsIndia → UNITED STATES42.1%India → SAUDI ARABIA12.3%

ImportsCHINA → India$508.4B BELGIUM → India$2.8B

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

NEXT PHARMA SOURCING S.A.S — Heparin Importer #17 | $2.4M Trade Value | TransData Nexus | TransData Nexus

NEXT PHARMA SOURCING S.A.S — Heparin Importer Profile

Pharmaceutical Importer · #17 buyer for Heparin · $2.4M import value · 48 shipments · COLOMBIA · DGFT Verified

NEXT PHARMA SOURCING S.A.S is the #17 importer of Heparin from India with $2.4M in import value and 48 verified shipments. NEXT PHARMA SOURCING S.A.S holds a 0.5% market share in Heparin imports based in COLOMBIA. The company sources from 1 verified supplier across 17 formulations shipped to 1 country. Overall, NEXT PHARMA SOURCING S.A.S imports 3 pharmaceutical products worth $3.1M across 3 therapeutic categories.

NEXT PHARMA SOURCING S.A.S — Heparin Import Profile: Suppliers, Formulations & Sources

NEXT PHARMA SOURCING S.A.S — Heparin import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Heparin to NEXT PHARMA SOURCING S.A.S?

Verified from 48 customs shipment records

Supplier	Value	Shipments	% Share
GLAND PHARMA LIMITED	$2.4M	48	100.0%

NEXT PHARMA SOURCING S.A.S sources Heparin from 1 verified Indian supplier based on 48 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.

How Does NEXT PHARMA SOURCING S.A.S Compare to Nearest Heparin Importers?

Buyers ranked immediately above and below #17 by import value

#	Buyer	Country	Import Value

Where Does NEXT PHARMA SOURCING S.A.S Import Heparin To?

Destination countries from 48 verified shipments

Country	Value	Shipments	Share
COLOMBIA	$2.4M	48	100.0%

NEXT PHARMA SOURCING S.A.S imports Heparin to 1 country. The primary destination is COLOMBIA receiving 100.0% of shipments worth $2.4M.

What Heparin Formulations Does NEXT PHARMA SOURCING S.A.S Import?

Formulation	Value	Shipments
HEPARIN INJECTION BP,25000IU/5ML,5ML VIAL	$919.1K	19
HEPARIN INJECTION BP,25000IU/5ML,5ML VIALNOS	$291.4K	6
HEPARIN INJECTION BP, 25000IU/5ML,5ML VIAL	$150.0K	3
HEPARIN INJECTION BP25000IU/5ML5ML VIAL	$150.0K	3
HEPARIN INJECTION BP, 25000IU/5ML,5ML VIALNOS	$146.1K	3
HEPARIN SODIUM INJ 25000IU/5ML (5000IU/M	$100.0K	2
HEPARIN INJECTION 25000IU/5ML,5ML VIAL	$100.0K	2
HEPARIN INJECTION 25000IU/5ML VIAL	$50.0K	1
HEPARIN SODIUM INJ 25000IU/5ML(5000IU/ML	$50.0K	1
LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0 4ML PRE FILLED SYRINGE	$50.0K	1

NEXT PHARMA SOURCING S.A.S imports 17 distinct Heparin formulations from India. The top formulation is HEPARIN INJECTION BP,25000IU/5ML,5ML VIAL with 19 shipments worth $919.1K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: NEXT PHARMA SOURCING S.A.S matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as NEXT PHARMA SOURCING S.A.S's capped import value divided by total capped export value for Heparin across all Indian exporters.
5.Verified Records: This page is backed by 48 individual customs records matching NEXT PHARMA SOURCING S.A.S importing Heparin, covering 17 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 854+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

16	ASCEND LABORATORIES SPA	CHILE	$2.1M	42	$50.0K
11	EVERSANA LIFE SCIENCE SERVICES LLC	UNITED STATES	$1.9M	38	$50.0K
17	NEXT PHARMA SOURCING S.A.S ★	COLOMBIA	$1.9M	38	$50.0K
9	E U PHARMACEUTICALS CO.,LTD	THAILAND	$1.4M	28	$50.0K
3	NUEVOS ETICOS NEOETHICALS, S.A.	GUATEMALA	$1.1M	22	$50.0K

Heparin

Heparin

NEXT PHARMA SOURCING S.A.S — Heparin Importer Profile

NEXT PHARMA SOURCING S.A.S — Heparin Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Heparin to NEXT PHARMA SOURCING S.A.S?

How Does NEXT PHARMA SOURCING S.A.S Compare to Nearest Heparin Importers?

Where Does NEXT PHARMA SOURCING S.A.S Import Heparin To?

What Heparin Formulations Does NEXT PHARMA SOURCING S.A.S Import?

Who Are the Top Buyers of Heparin from India and How Much Does NEXT PHARMA SOURCING S.A.S Import?

What Is the Average Order Value for NEXT PHARMA SOURCING S.A.S's Heparin Imports?

Who Supplies Heparin to NEXT PHARMA SOURCING S.A.S?

How Does NEXT PHARMA SOURCING S.A.S Compare to Other Heparin Importers?

About NEXT PHARMA SOURCING S.A.S

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Heparin Import Data for NEXT PHARMA SOURCING S.A.S

NEXT PHARMA SOURCING S.A.S × Heparin

Company Overview

Top Products by NEXT PHARMA SOURCING S.A.S

Related Analysis

Need Detailed Import Data?

Data Source